Anda di halaman 1dari 1

3096 Federal Register / Vol. 71, No.

12 / Thursday, January 19, 2006 / Notices

The proposed change may be The Director, Management Analysis and Developmental Disabilities, CDC, 1600
discussed at meetings of the Advisory Services Office, has been delegated the Clifton Road, NE., (E–86), Atlanta, Georgia
Board on Radiation and Worker Health authority to sign Federal Register notices 30333, telephone 404/498–3926, fax 404/
pertaining to announcements of meetings and 498–3550.
on January 9, 2006 (teleconference) and other committee management activities, for The Director, Management Analysis and
January 24–26, 2006 in Oak Ridge, TN. both CDC and the Agency for Toxic Services Office, has been delegated the
Only after the close of the public Substances and Disease Registry. authority to sign Federal Register notices
comment period will NIOSH make a pertaining to announcements of meetings and
Dated: January 12, 2006.
final decision regarding the proposed other committee management activities for
Alvin Hall, both the CDC and Agency for Toxic
change.
The Director, Management Analysis Director, Management Analysis and Services Substances and Disease Registry.
Office, Centers for Disease Control and
and Services Office, has been delegated Prevention.
Dated: January 10, 2006.
the authority to sign Federal Register Alvin Hall,
[FR Doc. E6–538 Filed 1–18–06; 8:45 am]
notices pertaining to announcements of Director, Management Analysis and Services
BILLING CODE 4163–18–P
meetings and other committee Office, Centers for Disease Control and
management activities for both the Prevention (CDC).
Centers for Disease Control and DEPARTMENT OF HEALTH AND [FR Doc. E6–543 Filed 1–18–06; 8:45 am]
Prevention and the Agency for Toxic HUMAN SERVICES BILLING CODE 4163–18–P
Substances and Disease Registry.
Dated: January 10, 2006. Centers for Disease Control and
Alvin Hall, Prevention DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Director, Management Analysis and Services
Office, Centers for Disease Control and
National Task Force on Fetal Alcohol
Syndrome and Fetal Alcohol Effect: Centers for Disease Control and
Prevention.
Meeting Prevention
[FR Doc. E6–542 Filed 1–18–06; 8:45 am]
BILLING CODE 4163–18–P In accordance with section 10(a)(2) of Advisory Committee on Immunization
the Federal Advisory Committee Act Practices: Meeting
(Pub. L. 92–463), the Centers for Disease
DEPARTMENT OF HEALTH AND Control and Prevention (CDC) In accordance with section 10(a)(2) of
HUMAN SERVICES announces the following federal the Federal Advisory Committee Act
advisory committee meeting: (Pub. L. 92–463), the Centers for Disease
Centers for Disease Control and Control and Prevention (CDC) announce
Prevention Name: National Task Force on Fetal the following Federal committee
Alcohol Syndrome and Fetal Alcohol Effect
(NTFFASFAE).
meeting.
Disease, Disability, and Injury
Times and Dates: 8:30 a.m.–4:30 p.m., Name: Advisory Committee on
Prevention and Control Special February 16, 2006. 8:30 a.m.–1 p.m., Immunization Practices (ACIP).
Emphasis Panel (SEP): Portfolio February 17, 2006. Time and Date: 8 a.m.–6:15 p.m., February
Review of Single Gene Disorders and Place: Embassy Suites Hotel Buckhead, 21, 2006.
Disability 3285 Peachtree Road, NE., Atlanta, Georgia 8 a.m.–5 p.m., February 22, 2006.
30305, telephone 404/261–7733, fax 404/ Place: Centers for Disease Control and
In accordance with section 10(a)(2) of 262–0522. Prevention, 1600 Clifton Road, NE., Building
the Federal Advisory Committee Act Status: Open to the public, limited only by 19, Room 232, Atlanta, Georgia 30333.
(Pub. L. 92–463), the Centers for Disease the space available. The meeting room Status: Open to the public, limited only by
Control and Prevention (CDC) accommodates approximately 65 people. the space available.
announces the following meeting: Purpose: The Secretary is authorized by the Purpose: The committee is charged with
Public Health Service Act, section 399G (42 advising the Director, CDC, on the
Name: Disease, Disability, and Injury U.S.C. Section 280f, as added by Pub. L. 105– appropriate uses of immunizing agents. In
Prevention and Control Special Emphasis 392), to establish a NTFFASFAE to: (1) Foster addition, under 42 U.S.C. 1396s, the
Panel (SEP): Portfolio Review of Single Gene coordination among all governmental committee is mandated to establish and
Disorders and Disability. agencies, academic bodies and community periodically review and, as appropriate,
Times and Dates: 9 a.m.–5 p.m., February groups that conduct or support Fetal Alcohol revise the list of vaccines for administration
10, 2006 (Closed). Syndrome (FAS) and Fetal Alcohol Effect to vaccine-eligible children through the
Place: National Center on Birth Defects and (FAE) research, programs and surveillance; Vaccines for Children (VFC) program, along
Developmental Disabilities, CDC, 12 and (2) to otherwise meet the general needs with schedules regarding the appropriate
Executive Park Drive, Atlanta, GA 30329, of populations actually or potentially periodicity, dosage, and contraindications
Telephone Number 404.498.3800. impacted by FAS and FAE. applicable to the vaccines.
Status: The meeting will be closed to the Matters to be Discussed: Agenda items Matters To Be Discussed: The agenda will
public in accordance with provisions set include: (1) Discussion of the Task Force’s include discussions on Rotavirus Vaccine
forth in section 552b(c)(4) and (6), Title 5 Post-Exposure working group activities; (2) which may include a possible VFC Vote;
U.S.C., and the Determination of the Director, presentations regarding prevention initiatives Human Papillomavirus Vaccine; general
Management Analysis and Services Office, from other relevant health topics such as recommendations on immunization;
CDC, pursuant to Public Law 92–463. tobacco use and HIV; (3) presentation and Influenza; Herpes Zoster Vaccine; Tetanus
Matters to be Discussed: The meeting will discussion regarding evidence-based review Toxoid, Diphtheria Toxoid, and Acellular
include the review and discussion of the of FAS prevention strategies; (4) Task Force Pertussis (Tdap) Vaccines; and departmental
Single Gene Disorders and Disability Team’s next steps; (5) updates from the Interagency updates.
strategies and activities. Coordinating Committee on FAS, CDC, and Agenda items are subject to change as
For Further Information Contact: Esther other federal agencies, and liaison members; priorities dictate.
sroberts on PROD1PC70 with NOTICES

Sumartojo, Acting Associate Director for (6) and scheduling of the next meeting. For Further Information Contact: Demetria
Science and Public Health, National Center Agenda items are subject to change as Gardner, Epidemiology and Surveillance
on Birth Defects and Developmental priorities dictate. Division, National Immunization Program,
Disabilities, CDC, 1600 Clifton Road, NE., For Further Information Contact: Mary CDC, 1600 Clifton Road, NE., (E–61), Atlanta,
Mailstop E–87, Atlanta, GA 30333, Kate Weber, M.P.H., Executive Secretary, Georgia 30333, telephone 404/639–8096, fax
Telephone Number 404.498.3800. National Center on Birth Defects and 404/639–8616.

VerDate Aug<31>2005 16:38 Jan 18, 2006 Jkt 208001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\19JAN1.SGM 19JAN1